Viewing Study NCT03466450


Ignite Creation Date: 2025-12-24 @ 5:12 PM
Ignite Modification Date: 2026-01-27 @ 7:18 PM
Study NCT ID: NCT03466450
Status: COMPLETED
Last Update Posted: 2024-03-28
First Post: 2018-02-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Glasdegib (PF-04449913) With Temozolomide Newly Diagnosed Glioblastoma
Sponsor: Grupo Español de Investigación en Neurooncología
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: GEINO-1602
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators